Influencing Factors for the Acceptability of Accessing HIV Pre-exposure Prophylaxis via Community Pharmacies in Wales

被引:0
|
作者
Gillespie, David [1 ]
Williams, Adam D. N. [1 ]
Ma, Richard [2 ]
Couzens, Zoe [3 ]
Hood, Kerenza [1 ]
Hughes, Dyfrig A. [4 ]
Mantzourani, Efi [5 ]
Cochrane, Eleanor [6 ]
Wood, Fiona [7 ,8 ]
机构
[1] Cardiff Univ, Coll Biomed & Life Sci, Ctr Trials Res, Sch Med, Cardiff, Wales
[2] Univ Bristol, Ctr Acad Primary Care, Bristol Med Sch, Bristol, England
[3] Publ Hlth Wales NHS Trust, Cardiff, Wales
[4] Bangor Univ, Ctr Hlth Econ & Med Evaluat, Bangor, Wales
[5] Cardiff Univ, Coll Biomed & Life Sci, Sch Pharm, Cardiff, Wales
[6] Hlth Educ & Improvement Wales, Cardiff, Wales
[7] Cardiff Univ, Coll Biomed & Life Sci, Sch Med, Div Populat Med, Cardiff, Wales
[8] Cardiff Univ, Coll Biomed & Life Sci, PRIME Ctr Wales, Sch Med, Cardiff, Wales
关键词
community pharmacy; healthcare access; HIV; pre-exposure prophylaxis; primary care; qualitative research;
D O I
10.1111/hex.70247
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Introduction: HIV prevention methods, such as pre-exposure prophylaxis (PrEP), have been a significant contributing factor to a global decline in HIV transmission. PrEP has been available through the NHS in Wales since 2017. However, access is exclusively via sexual health clinics, and those accessing PrEP do not reflect those being diagnosed with HIV. Widening access beyond sexual health clinics may be one approach to encourage more equitable uptake, and there is growing interest in offering PrEP services in community pharmacies. We, therefore, aimed to explore the acceptability of PrEP services being delivered through community pharmacies among prospective service users. Methods: We conducted a qualitative interview study of people living in Wales who either (i) currently access, (ii) previously accessed or are (iii) considering accessing PrEP via a sexual health clinic. Participants were recruited via community networks, and interviews were conducted virtually. Our topic guide was informed by Levesque's conceptual framework of access to healthcare, and we used reflexive thematic analysis. Results: We interviewed 24 participants and included data from 20 in the analysis. Four themes were generated: experiences of accessing PrEP via sexual health clinics, the prospect of PrEP access via community pharmacies, other community settings in which PrEP may be accessed and concerns around integrated healthcare and healthcare data. Conclusion: PrEP access via community pharmacy is likely to be an acceptable option for people. There are uncertainties surrounding what a PrEP service would look like in a community pharmacy setting, and this would need clarifying to prospective users to increase the salience of access. Patient and Public Contribution: A team-based approach was taken for developing the topic guide and agreeing on the codes for this study. This included people with lived experience of accessing PrEP in Wales.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] A Review of Studies on HIV Pre-Exposure Prophylaxis in Community Pharmacies in States with Restrictive Pharmacist Prescription Authority in the United States
    Wang, Hongmei
    Guinn, Dominique
    Ramisetty, Xavier Roshitha
    Giordano, Thomas P.
    Poon, Ivy O.
    PHARMACY, 2024, 12 (05)
  • [32] HIV Pre-exposure Prophylaxis in the LGBTQ Community: A Review of Practice and Places
    Dorce-Menard, Jennifer
    Okobi, Okelue E.
    Grieb, Jesse
    Saunders, Nzingha
    Harberger, Seneca
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [33] Acceptability and feasibility of HIV pre-exposure prophylaxis (PrEP) in Southeast Asia: A scoping review
    Espera, Justitia Roma
    Reyes, Chaia Alyssa
    Sarmiento, Erla Grace
    Sitchon, Czarina Mae
    Zantua, Roueline
    Carandang, Rogie Royce
    INTERNATIONAL JOURNAL OF STD & AIDS, 2025, 36 (04) : 260 - 274
  • [34] Portuguese health care providers' knowledge, attitudes, and acceptability of HIV pre-exposure prophylaxis
    Goncalves, Rui Baptista
    Marreiros, Ana
    Augusto, Goncalo Figueiredo
    HIV & AIDS REVIEW, 2018, 17 (04): : 249 - 258
  • [35] Acceptability of HIV Pre-Exposure Prophylaxis Among Transgender Women in India: A Qualitative Investigation
    Chakrapani, Venkatesan
    Shunmugam, Murali
    Rawat, Shruta
    Baruah, Dicky
    Nelson, Ruban
    Newman, Peter A.
    AIDS PATIENT CARE AND STDS, 2020, 34 (02) : 92 - 98
  • [36] Acceptability of HIV pre-exposure prophylaxis in China: A systematic review and meta-analysis
    Yuan, Defu
    Yin, Yueqi
    Chen, Jianshuang
    Lu, Jing
    Zhou, Ying
    Fu, Gengfeng
    Wang, Bei
    INTERNATIONAL JOURNAL OF STD & AIDS, 2022, 33 (03) : 218 - 231
  • [37] HIV pre-exposure prophylaxis (PrEP) awareness and acceptability among trans women: a review
    de Carvalho, Nathalia Pacifico
    Pinto Mendicino, Cassia Cristina
    Fonseca Candido, Raissa Carolina
    Dutra Alecrim, Denyr Jeferson
    Menezes de Padua, Cristiane Aparecida
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2019, 31 (10): : 1234 - 1240
  • [38] Awareness, acceptability, and intention to initiate HIV pre-exposure prophylaxis among pregnant women
    Scott, Rachel K.
    Hull, Shawnika J.
    Richards, Robin C.
    Klemmer, Kristen
    Salmoran, Frida
    Huang, Jim C.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2022, 34 (02): : 201 - 213
  • [39] Acceptability and willingness of HIV pre-exposure prophylaxis amongst female sex workers in China
    Poon, Adrienne N.
    Han, Lifeng
    Li, Zhijun
    Zhou, Chu
    Li, Yan
    Huang, Lu
    Liao, Meizhen
    Shepard, Colin
    Bulterys, Marc
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2019, 31 (12): : 1555 - 1564
  • [40] Enhancing HIV Pre-exposure Prophylaxis Practices via an Educational Intervention
    Newman, Rebecca
    Katchi, Tasleem
    Karass, Michael
    Gennarelli, Melissa
    Goutis, Jason
    Kifayat, Alina
    Solanki, Shantanu
    Yandrapalli, Srikanth
    Forman, Leanne
    Nabors, Christopher
    AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (04) : E462 - E468